Personalis Inc.
Personalis Inc. (oncology diagnostics and genomic analysis) netted $144m through its initial public offering. The company sold 9.1 million common...
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced June 2019.
Personalis Inc.
Personalis Inc. (oncology diagnostics and genomic analysis) netted $144m through its initial public offering. The company sold 9.1 million common...